Concord Biotech (BOM:543960) Other Long-Term Liabilities : ₹300 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Concord Biotech Other Long-Term Liabilities?

Concord Biotech's other long-term liabilities for the quarter that ended in Mar. 2024 was ₹300 Mil.

Concord Biotech's quarterly other long-term liabilities increased from Mar. 2023 (₹234 Mil) to Sep. 2023 (₹266 Mil) and increased from Sep. 2023 (₹266 Mil) to Mar. 2024 (₹300 Mil).

Concord Biotech's annual other long-term liabilities increased from Mar. 2022 (₹210 Mil) to Mar. 2023 (₹234 Mil) and increased from Mar. 2023 (₹234 Mil) to Mar. 2024 (₹300 Mil).

Concord Biotech Other Long-Term Liabilities Historical Data

The historical data trend for Concord Biotech's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Biotech Other Long-Term Liabilities Chart

Concord Biotech Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Other Long-Term Liabilities

Concord Biotech Semi-Annual Data
	Mar20	Mar21	Mar22	Sep22	Mar23	Sep23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial			-	-	-	-	-

Concord Biotech Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Concord Biotech Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Concord Biotech's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Biotech (BOM:543960) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (BOM:543960) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

CONCORDBIO:India

Address

Iscon Cross Road, S.G. Highway, 16th floor, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015

Website

https://www.concordbiotech.com

Concord Biotech Ltd is a Research & development-driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations.

Concord Biotech (BOM:543960) Headlines

No Headlines